Skip to main content
Premium Trial:

Request an Annual Quote

Keeps on Coming

Roche is letting 6 percent of its workforce, or about 4,800 people, go, reports Ed Silverman at Pharmalot. A Roche statement on its Operational Excellence Program says that 800 cuts will be to product development staff and 600 cuts to research and early development positions, while sales and marketing will bear the largest share of the cuts, with a loss of 2,650 positions. In addition, there will be reorganization to some technical operations. The cuts will take place over the next two years and is expected to save the company about $2.4 billion.

Our sister publication GenomeWeb Daily News has more here.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.